(-0.07%) 5 304.50 points
(-0.04%) 40 128 points
(-0.09%) 18 487 points
(0.70%) $81.92
(-1.57%) $1.691
(0.26%) $2 218.50
(-0.62%) $24.60
(0.06%) $910.25
(0.44%) $0.927
(0.69%) $10.84
(0.26%) $0.793
(-0.12%) $92.33
Live Chart Being Loaded With Signals
Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform...
Stats | |
---|---|
Today's Volume | 10 000.00 |
Average Volume | 13 596.00 |
Market Cap | 28 143.00 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.00750 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-06-06 | Petkanas Dean | Sell | 10 000 | Common Stock |
2022-06-07 | Petkanas Dean | Sell | 50 000 | Common Stock |
2022-06-08 | Petkanas Dean | Sell | 21 836 | Common Stock |
2022-06-09 | Petkanas Dean | Sell | 238 164 | Common Stock |
2022-06-13 | Petkanas Dean | Sell | 300 000 | Common Stock |
INSIDER POWER |
---|
-100.00 |
Last 56 transactions |
Buy: 20 518 991 | Sell: 5 700 000 |
Volume Correlation
Neuropathix, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Neuropathix, Inc. Correlation - Currency/Commodity
Neuropathix, Inc. Financials
Annual | 2021 |
Revenue: | $183 477 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0480 |
Q1 | 2022 |
Revenue: | $207 980 |
Gross Profit: | $207 980 (100.00 %) |
EPS: | $-0.0206 |
Q4 | 2021 |
Revenue: | $151 477 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.00840 |
Q3 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.0100 |
Financial Reports:
No articles found.
Neuropathix, Inc.
Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators